Boston Scientific Announces Participation in the J.P. Morgan Healthcare Conference and Conference Call Discussing Fourth Quarter 2024 Results
Boston Scientific (NYSE: BSX) has announced two upcoming investor events. First, the company will participate in the 43rd Annual J.P. Morgan Healthcare Conference on January 13, 2025, in San Francisco. CEO Mike Mahoney will present at 5:15 p.m. PT, joined by CFO Dan Brennan and CMO Dr. Kenneth Stein for a Q&A session.
Additionally, BSX will host its fourth quarter 2024 earnings call on February 5, 2025, at 8:00 a.m. ET. Financial results will be released prior to the call. Both events will be accessible via webcast on the company's investor relations website, with replays available approximately one hour after each event.
Boston Scientific (NYSE: BSX) ha annunciato due eventi per gli investitori in arrivo. Prima di tutto, l'azienda parteciperà alla 43ª Conferenza Annuale sulla Salute J.P. Morgan il 13 gennaio 2025, a San Francisco. Il CEO Mike Mahoney presenterà alle 17:15 PT, insieme al CFO Dan Brennan e al CMO Dr. Kenneth Stein per una sessione di domande e risposte.
Inoltre, BSX ospiterà la sua chiamata sugli utili del quarto trimestre 2024 il 5 febbraio 2025, alle 8:00 ET. I risultati finanziari saranno rilasciati prima della chiamata. Entrambi gli eventi saranno accessibili tramite webcast sul sito web delle relazioni con gli investitori dell'azienda, con registrazioni disponibili circa un'ora dopo ciascun evento.
Boston Scientific (NYSE: BSX) ha anunciado dos próximos eventos para inversores. En primer lugar, la empresa participará en la 43ª Conferencia Anual de Salud J.P. Morgan el 13 de enero de 2025, en San Francisco. El CEO Mike Mahoney presentará a las 5:15 p.m. PT, acompañado del CFO Dan Brennan y del CMO Dr. Kenneth Stein para una sesión de preguntas y respuestas.
Además, BSX realizará su llamada de ganancias del cuarto trimestre de 2024 el 5 de febrero de 2025, a las 8:00 a.m. ET. Los resultados financieros se publicarán antes de la llamada. Ambos eventos serán accesibles a través de un webcast en el sitio web de relaciones con inversores de la empresa, con repeticiones disponibles aproximadamente una hora después de cada evento.
보스턴 사이언티픽 (NYSE: BSX)가 두 가지 투자자 이벤트를 발표했습니다. 첫째, 회사는 2025년 1월 13일 샌프란시스코에서 열리는 제43회 JP모건 헬스케어 컨퍼런스에 참가합니다. CEO 마이크 마호니는 오후 5시 15분 PT에 발표하며, CFO 댄 브레넌과 CMO 케네스 스타인 박사가 Q&A 세션에 참여합니다.
또한 BSX는 2025년 2월 5일 오전 8시 ET에 2024년 4분기 실적 발표 전화 회의를 주최합니다. 재무 결과는 전화 회의 전에 발표됩니다. 두 이벤트 모두 회사의 투자자 관계 웹사이트를 통해 웹캐스트로 접근 가능하며, 각 이벤트 후 약 한 시간 후에 재방송이 제공됩니다.
Boston Scientific (NYSE: BSX) a annoncé deux prochains événements pour les investisseurs. Tout d'abord, l'entreprise participera à la 43e Conférence Annuelle sur la Santé J.P. Morgan le 13 janvier 2025 à San Francisco. Le PDG Mike Mahoney présentera à 17h15 PT, accompagné du CFO Dan Brennan et du CMO Dr. Kenneth Stein pour une session de questions-réponses.
De plus, BSX organisera sa conférence téléphonique sur les résultats du quatrième trimestre 2024 le 5 février 2025 à 8h00 ET. Les résultats financiers seront publiés avant l'appel. Les deux événements seront accessibles par webcast sur le site de relations avec les investisseurs de l'entreprise, avec des rediffusions disponibles environ une heure après chaque événement.
Boston Scientific (NYSE: BSX) hat zwei bevorstehende Investorenveranstaltungen angekündigt. Zunächst wird das Unternehmen am 13. Januar 2025 an der 43. J.P. Morgan Healthcare-Konferenz in San Francisco teilnehmen. CEO Mike Mahoney wird um 17:15 Uhr PT präsentieren, begleitet von CFO Dan Brennan und CMO Dr. Kenneth Stein für eine Fragen- und Antworten-Sitzung.
Darüber hinaus wird BSX am 5. Februar 2025 um 8:00 Uhr ET seine Gewinnaufruf für das vierte Quartal 2024 veranstalten. Die finanziellen Ergebnisse werden vor dem Anruf veröffentlicht. Beide Veranstaltungen werden über ein Webcast auf der Investor-Relations-Website des Unternehmens zugänglich sein, mit Wiederholungen, die etwa eine Stunde nach jeder Veranstaltung verfügbar sind.
- None.
- None.
Additionally, the company will webcast its conference call discussing financial results and business highlights for the fourth quarter ended December 31, 2024, on Wednesday, February 5, 2025, at 8:00 a.m. ET. The call will be hosted by Mike Mahoney and Dan Brennan. The company will issue a news release announcing financial results for the fourth quarter on February 5 prior to the conference call.
A live webcast and replay for each event will be accessible at htts://investors.bostonscientific.com. The replays will be available approximately one hour following the completion of each event.
About Boston Scientific
Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 45 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of health care. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. Learn more at www.bostonscientific.com and connect on LinkedIn and X, formerly Twitter.
CONTACTS:
Chanel Hastings
Media Relations
+1 (508) 382-0288
Chanel.Hastings@bsci.com
Jon Monson
Investor Relations
+1 (508) 683-5450
BSXInvestorRelations@bsci.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/boston-scientific-announces-participation-in-the-jp-morgan-healthcare-conference-and-conference-call-discussing-fourth-quarter-2024-results-302340448.html
SOURCE Boston Scientific Corporation
FAQ
When will Boston Scientific (BSX) release Q4 2024 earnings?
When is Boston Scientific's (BSX) presentation at the 2025 J.P. Morgan Healthcare Conference?
Who will represent Boston Scientific (BSX) at the 2025 J.P. Morgan Healthcare Conference?
Where can investors watch Boston Scientific's (BSX) Q4 2024 earnings call?
